BioGene Therapeutics
Austin, US · Founded 2024 · Texas corporation
Biotech
Founders & leadership
SV
STEPHEN VAN DEVENTERExecutive Officer, Director
DS
DEEPAK SAMPATHDirector
PL
PATROSKI LAWSONDirector
SG
STEVE GLOVERDirector
RP
RAJ PRUTHIDirector
DT
DAVID TYRONNE HOWTONDirector
Reported raises · per SEC filings
Form D private placements▶$3MraisedAug 2026 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedAug 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- STEPHEN VAN DEVENTERExecutive Officer, Director
- DEEPAK SAMPATHDirector
- PATROSKI LAWSONDirector
- STEVE GLOVERDirector
- RAJ PRUTHIDirector
- DAVID TYRONNE HOWTONDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Jun 2026
- Incorporated
- Corporation, Texas, 2024
- Federal exemptions
- 06b
▶$250KraisedAug 2026 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedAug 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- STEPHEN VAN DEVENTERExecutive Officer, Director
- DEEPAK SAMPATHDirector
- PATROSKI LAWSONDirector
- STEVE GLOVERDirector
- RAJ PRUTHIDirector
- DAVID TYRONNE HOWTONDirector
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Aug 2025
- Incorporated
- Corporation, Texas, 2024
- Federal exemptions
- 06b
▶$250KraisedAug 2026 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedAug 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- STEPHEN VAN DEVENTERExecutive Officer, Director
- DEEPAK SAMPATHDirector
- PATROSKI LAWSONDirector
- STEVE GLOVERDirector
- RAJ PRUTHIDirector
- DAVID TYRONNE HOWTONDirector
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Aug 2025
- Incorporated
- Corporation, Texas, 2024
- Federal exemptions
- 06b
▶$3MraisedAug 2026 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedAug 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- STEPHEN VAN DEVENTERExecutive Officer, Director
- DEEPAK SAMPATHDirector
- PATROSKI LAWSONDirector
- STEVE GLOVERDirector
- RAJ PRUTHIDirector
- DAVID TYRONNE HOWTONDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Mar 2026
- Incorporated
- Corporation, Texas, 2024
- Federal exemptions
- 06b
▶$4.5MraisedJul 2026 · 6 investors · BiotechnologyRule 506(b)
▶$4.5MraisedJul 2026 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- STEPHEN VAN DEVENTERExecutive Officer, Director
- DEEPAK SAMPATHDirector
- PATROSKI LAWSONDirector
- STEVE GLOVERDirector
- RAJ PRUTHIDirector
- DAVID TYRONNE HOWTONDirector
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- First sale
- Apr 2025
- Incorporated
- Corporation, Texas, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.